# Prelude Therapeutics Inc: Form SC 13D, filed Sep 30, 2020

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: SC 13D
- Filed: 2020-09-30
- Accepted by EDGAR: Sep 30, 2020, 17:25 ET
- Period: not reported
- Accession: 0001104659-20-110491
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000110465920110491/tm2032041d1_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000110465920110491/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000110465920110491/tm2032041d1_sc13d.htm

Filed Sep 30, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-110491. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
